TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells. (Q37028027)
Jump to navigation
Jump to search
scientific article published on 29 April 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells. |
scientific article published on 29 April 2013 |
Statements
TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells (English)
Chwee Ming Lim
Ryan Stephenson
Andres M Salazar
1 reference
1 reference
1 reference
1 reference